Major Depressive Disorder
The MD Magazine Major Depressive Disorder condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Genetic Links between Depression and Obesity Remain Unclear
Studies have shown that major depressive disorder (MDD) has a strong link to genetic factors, and many clinicians and researchers believe the same to be true for obesity.
Study results show that mood, whether positive or negative, may impact the discomfort associated with rheumatoid arthritis.
A clinical trial is evaluating the use of the Kokoro app to deliver a smartphone-based CBT program to patients being treated for depression.
A study evaluating glycemic response following insulin initiation for type 2 diabetes mellitus found that patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline and higher HbA1c levels.
The US Food and Drug Administration (FDA) announced the approval of Rexulti (brexpiprazole) as a treatment option for adults with schizophrenia or major depressive disorder (MDD).
Often, pain associated with rheumatoid arthritis (RA) can impact every aspect of a person’s life, leading to isolation, depression, anxiety, lack of physical activity, and a host of other ills. Most experts agree that self-support tools—along with emotional support from loved ones, fellow RA patients, health care providers, and friends—is a key component of managing RA.
New research provides more evidence of a possible link between selective serotonin reuptake inhibitor (SSRI) antidepressant use early in pregnancy and a small increased risk of birth defects.

Most Popular

$vacMongoViewPlus$ $vAR$